Bavarian Nordic has secured support to make a late move for the COVID-19 vaccine market. Having missed out on the first phase of the global vaccination campaign, Bavarian Nordic is set to receive up to 800 million Danish krone ($126 million) from the Danish government to muscle in on the booster market.